Search Results

Hazardous Interactions Between Food, Herbs, and Drugs in the First Stage of Biotransformation: Case Reports of Adverse Drug Interactions in Humans.

• Authors : Bukowska, Bożena¹ (AUTHOR) ; Grzegorowska, Anna^1,2 (AUTHOR); Szczerkowska-Majchrzak, Eliza^2,3 (AUTHOR)

Subjects: *Poisons; *Monoamine oxidase; *Cranberry juice

• Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 11, p5188. 37p.

Record details

Klinicky významné liekové interakcie pri podávaní nirmatrelviru/ritonaviru u pacientov s chronickou farmakoterapiou.

• Authors : Mačeková, Zuzana¹ ; Tomášová, Veronika²; Pajerová, Katarína³

• Source: Klinická Farmakologie a Farmacie. Apr2025, Vol. 39 Issue 1, p5-13. 9p.

Record details

Development and Validation of an Approach to Assessing Clinical Relevance of Potential Drug–Drug Interactions Inducing Rare but Serious Adverse Events.

• Authors : Song, Menghuan^1,2 (AUTHOR); Zhou, Hui³ (AUTHOR); Yang, Zhirong^4,5 (AUTHOR)

• Source: CTS: Clinical & Translational Science. May2025, Vol. 18 Issue 5, p1-13. 13p.

Record details

Flavonoids and Furanocoumarins Involved in Drug Interactions.

• Authors : Berteina-Raboin, Sabine¹ (AUTHOR)

Subjects: *Organic anion transporters; *Drug interactions; *Cytochrome P-450

• Source: Molecules. Apr2025, Vol. 30 Issue 8, p1676. 21p.

Record details

Farmakokinetické lékové interakce přímo působících perorálních antikoagulancií.

• Authors : Suchopár, Josef¹ ; Prokeš, Michal¹; Suchopár, Štěpán¹

• Source: Klinická Farmakologie a Farmacie. Apr2025, Vol. 39 Issue 1, p22-33. 12p.

Record details

Molecular Precision Medicine: Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions Between Lidocaine and Rocuronium/Propofol/Paracetamol.

• Authors : Silva, Abigail^1,2 (AUTHOR); Mourão, Joana^2,3,4 (AUTHOR); Vale, Nuno^1,2,3,5 (AUTHOR)

Subjects: *Drug side effects; *Drug interactions; *Drug metabolism

• Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 4, p1506. 39p.

Record details

Managing drug–drug interactions with mavacamten: A focus on combined use of antiarrhythmic drugs and anticoagulants

• Authors : Ricci, Fabrizio; Molinari, Lorenzo V.; Mansour, Davide ...

Subjects: Medical and Health Sciences; Clinical Medicine; Cardiology and Cardiovascular Disease

• Source: Heart Rhythm. 22(2):510-525

Record details

Prevalence of OATP1B‐Mediated Drug–Drug Interactions in an Academic Medical Center.

• Authors : Bories, Mathilde¹ (AUTHOR); Malnoë, David^2,3,4 (AUTHOR); Le Corre, Pascal^2,3,4 (AUTHOR) pascal.le‐‐rennes1.fr

• Source: CTS: Clinical & Translational Science. Jun2025, Vol. 18 Issue 6, p1-7. 7p.

Record details

Role of physiologically based biopharmaceutics modeling in predicting and circumventing the drug-drug interactions of tyrosine kinase inhibitors with acid-reducing agents.

• Authors : Kollipara, Sivacharan¹; Sivadasu, Praveen¹ ; Rashmi, S. R.²

• Source: Journal of Applied Pharmaceutical Science. Jun2025, Vol. 15 Issue 6, p55-69. 15p.

Record details

Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug–Drug Interactions.

• Authors : Thakur, Aarzoo^1,2 (AUTHOR); Mathialagan, Sumathy¹ (AUTHOR); Kimoto, Emi¹ (AUTHOR)

• Source: CPT: Pharmacometrics & Systems Pharmacology. May2025, Vol. 14 Issue 5, p904-917. 14p.

Record details